Upadacitinib in Patients Hospitalized With Acute Severe Ulcerative Colitis

NCT07502339 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

UC - Ulcerative Colitis

Interventions

DRUG: Upadacitinib

Sponsor

University of California, San Francisco

Collaborators

[object Object]